REOZALIMAB

UNII:	1LO2LQW7QG
Formula:
Preferred Substance Name:	REOZALIMAB
GSRS Full Record:	1LO2LQW7QG i

2445259-99-2
IMMUNOGLOBULIN G1 (240-ALANINE,241-ALANINE,271-SERINE,189-LYSINE,220-ARGININE,356-VALINE,357-TYROSINE,411-ALANINE,413-VALINE), ANTI-(HUMAN PROGRAMMED DEATH-LIGAND 1) (HUMAN MONOCLONAL LY3300054 .GAMMA.1-CHAIN), DISULFIDE WITH (179-GLUTAMIC ACID,181-GLUTAMIC ACID) HUMAN MONOCLONAL LY3300054 .LAMBDA.-CHAIN, (232->229'),(235->232')-BIS(DISULFIDE) WITH IMMUNOGLOBULIN G1 (237-ALANINE,238-ALANINE,268-SERINE,131-GLUTAMIC ACID,150-THREONINE,178-GLUTAMIC ACID,217-ARGININE,353-VALINE,369-LEUCINE,395-LEUCINE,397-TRYPTOPHAN) ANTI-(HUMAN PROGRAMMED CELL DEATH PROTEIN 1) (HUMAN MONOCLONAL LY03342903 .GAMMA.1-CHAIN) DISULFIDE WITH (131-ARGININE,133-GLYCINE,176-ARGININE) HUMAN MONOCLONAL LY03342903 .KAPPA.-CHAIN
LY3434172
LY-3434172
LY3434172, A PD-1 AND PD-L1 BISPECIFIC ANTIBODY
REOZALIMAB [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

REOZALIMAB

Synonyms and Mappings

Resources